Tripos Discovery Research Ltd., a Subsidiary of Commonwealth Biotechnologies, Inc., Enters Agreement with CombinatoRx, Incorporated to Optimize Novel Compounds

RICHMOND, Va. & BUDE, England--(BUSINESS WIRE)--Tripos Discovery Research Limited (TDR), a wholly owned subsidiary of Commonwealth Biotechnologies, Inc. (CBI) (NASDAQ Capital Market:CBTE) and a leading provider of drug discovery chemistry services and small molecule products, announces today that it has entered into a service agreement with CombinatoRx, Incorporated (CombinatoRx) (NASDAQ:CRXX), a company specializing in the new field of synergistic combination pharmaceuticals.